US BROKER MOVES: WST upgraded at Barclays; FCEL upgraded at Canaccord

UPGRADES

• West Pharmaceutical Services (WST) Upgraded to Overweight at Barclays; PT USD 400 (prev. USD 310)
• PTC Therapeutics (PTCT) Upgraded to Buy at Citi; PT USD 108 (prev. USD 75)
• PAR Technology (PAR) Upgraded to Neutral at JPMorgan; PT USD 16 (prev. USD 12)
• FuelCell Energy (FCEL) Upgraded to Buy at Canaccord; PT USD 30 (prev. USD 12)
• Cleveland-Cliffs (CLF) Upgraded to Hold at GLJ Research
• Brady Corporation (BRC) Upgraded to Buy at Sidoti; PT USD 103

INITIATIONS

• Zymeworks (ZYME) Initiated at New Buy at Truist Securities; PT USD 28
• VEON (VEON) Initiated at New Outperform at Northland; PT USD 70
• Park Aerospace (PKE) Initiated at New Market Outperform at Citizens; PT USD 42
• Magnite (MGNI) Initiated at New Buy at BTIG; PT USD 20
• LSI Industries (LYTS) Initiated at New Outperform at Oppenheimer; PT USD 30
• Grand Canyon Education (LOPE) Initiated at New Buy at Truist Securities; PT USD 200
• Jazz Pharmaceuticals (JAZZ) Initiated at New Buy at Truist Securities; PT USD 256
• International Flavors & Fragrances (IFF) Initiated at New Buy at Benchmark; PT USD 100
• Barrick Gold (GOLD) Initiated at New Buy at Canaccord; PT USD 70
• Precision BioSciences (DTIL) Initiated at New Outperform at Oppenheimer; PT USD 20
• CF Industries (CF) Initiated at New Buy (1) at Huatai Financial; PT USD 195.72